<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-3-54-59</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1299</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Инфекционный статус больных с оптическим невритом воспалительной и демиелинизирующей этиологии</article-title><trans-title-group xml:lang="en"><trans-title>The infectious status of patients with optic neuritis of inflammatory and demyelinating etiologies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8480-0894</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нероев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neroev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Владимирович Нероев - академик РАН, д-р мед. наук, профессор, директор, заведующий кафедрой глазных болезней</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p><p>ул. Делегатская, д. 20, стр. 1, Москва, 127473</p></bio><bio xml:lang="en"><p>Vladimir V. Neroev - Academician of the RAS, Dr. of Med. Sci., professor, director, head of chair of eye diseases</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p><p>20, Bldg. 1, Delegatskaya St., Moscow, 127473</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8099-592X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеева</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseeva</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Константиновна Елисеева - канд. мед. наук, научный сотрудник отдела ультразвуковых исследований</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Elena K. Eliseeva - Cand. of Med. Sci., researcher of ultrasound diagnostic department</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">eliseevaek@ya.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7052-3294</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кричевская</surname><given-names>Г. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krichevskaya</surname><given-names>G. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галина Исааковна Кричевская - канд. мед. наук, врач клинической лабораторной диагностики отдела иммунологии и вирусологии</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Galina I. Krichevskaya - Cand. of Med. Sci., doctor of clinical laboratory diagnostics, department of immunology and virusology</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8754-9802</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдова</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydova</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галина Анатольевна Давыдова - канд. мед. наук, научный сотрудник отдела патологии сетчатки</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Galina A. Davydova - Cand. of Med. Sci., researcher, department of pathology of the retina and optic nerve</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1072-9968</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>M. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Николаевна Захарова - д-р мед. наук, главный научный сотрудник, руководитель 6-го неврологического отделения</p><p>Волоколамское шоссе, д. 80, Москва, 125367</p></bio><bio xml:lang="en"><p>Maria N. Zakharova - Dr. of Med. Sci., head of 6th department</p><p>80, Volokolamskoye Hgwy, 125367, Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России; ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases; Moscow Evdokimov State Medical Stomatological University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр неврологии» Минобрнауки России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Center of Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2023</year></pub-date><volume>16</volume><issue>3</issue><fpage>54</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нероев В.В., Елисеева Е.К., Кричевская Г.И., Давыдова Г.А., Захарова М.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Нероев В.В., Елисеева Е.К., Кричевская Г.И., Давыдова Г.А., Захарова М.Н.</copyright-holder><copyright-holder xml:lang="en">Neroev V.V., Eliseeva E.K., Krichevskaya G.I., Davydova G.A., Zakharova M.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1299">https://roj.igb.ru/jour/article/view/1299</self-uri><abstract><p>Цель работы – изучить распространенность различных хронических инфекций, частоту их реактивации и характерные ассоциации микроорганизмов у больных с оптическим невритом (ОН) различной этиологии. Материал и методы. У 13 пациентов с ОН воспалительной этиологии и 12 пациентов с ОН при рассеянном склерозе с помощью иммуноферментного анализа исследовалась сыворотка крови на широкий спектр инфекционных возбудителей.Результаты. У всех пациентов выявлено микст-инфицирование различными микроорганизмами, у 64% наблюдалась ассоциация 4 и более возбудителей. Пациенты обеих групп инфицированы вирусом Эпштейна-Барр (100%), цитомегаловирусом (92%) и вирусами простого герпеса (92%) 1 и/или 2 типа с серологическими признаками их реактивации. Сочетание герпес-вирусной реактивации, токсоплазменного и урогенитального инфицирования чаще определялось у больных с демиелинизирующим ОН. У пациентов с рассеянным склерозом документирована взаимосвязь: чем выше степень инфицированности (комбинацией из пяти или более возбудителей), тем ниже острота зрения в дебюте заболевания (р&lt;0,05) и тем неблагоприятнее визуальный прогноз.Заключение. Смешанное инфицирование может играть важную роль в патогенезе ОН, в том числе и демиелинизирующей природы, в качестве триггерного или отягощающего фактора.</p></abstract><trans-abstract xml:lang="en"><p>Purpose: to study the prevalence of various chronic infections, the frequency of their reactivation and characteristic associations of microorganisms in patients with optic neuritis of various etiologies.Material and methods. 13 patients with optic neuritis (ON) and 12 patients with ON and multiple sclerosis were tested for a broad range of infectious agents in their blood serum.Results. All patients were shown to have mixed infections; 64 % of them had an association of 4 or more infectious agents. The patients of both groups were infected with Epstein-Barr virus (100 %), Cytomegalovirus (92 %) and Herpex simplex viruses (92 %) types 1 and/or 2 with serological signs of their reactivation. The combination of Herpes virus reactivation, Toxoplasma and urogenital infection was more often detected in patients with demyelinating ON. In patients with multiple sclerosis, a mutual correlation was detected: the higher the degree of infection (combination of 5 or more pathogens), the lower the visual acuity at the onset of the disease (p &lt; 0.05) and the less favourable the vision prognosis.Conclusion. Possibly, mixed infection may play an important role in the pathogenesis of ON, including that of demyelinating etiology, as a trigger or an aggravating factor.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>оптический неврит</kwd><kwd>рассеянный склероз</kwd><kwd>иммуноферментный анализ</kwd><kwd>офтальмотропные хронические инфекции</kwd></kwd-group><kwd-group xml:lang="en"><kwd>optic neuritis</kwd><kwd>multiple sclerosis</kwd><kwd>ELIA</kwd><kwd>ophthalmotropic chronic infections</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеева Е.К., Нероев В.В., Зуева М.В., Цапенко И.В., Захарова М.Н. Оптический неврит на фоне рассеянного склероза (обзор литературы и результаты собственного исследования). Точка зрения. Восток—Запад. 2018; 2:112–5. https://doi.org/10.25276/2410-1257-2018-2-112-115</mixed-citation><mixed-citation xml:lang="en">Eliseeva E.K., Neroev V.V., Zueva M.V., Tsapenko I.V., Zakharova M.N. Optic neuritis with multiple sclerosis (review of literature and own data). Point of View. East—West. 2018; 2:112–5 (in Russ.). https://doi.org/10.25276/2410-1257-2018-2-112-115</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Поваляева Д.А., Егоров В.В., Смолякова Г.П., Данилова Л.П., Еманова Л.П. Клинико-иммунологические аспекты в этиологической диагностике идиопатических оптических невритов. Современные технологии в офтальмологии. 2018; 2:232-36.</mixed-citation><mixed-citation xml:lang="en">Povalyaeva D.A., Egorov V.V., Smoliakova G.P., Danilova L.P., Emanova L.P. Clinical and immunological aspects in etiological diagnosis of idiopathic optic neuritis. Modern technologies in ophthalmology. 2018; (2): 232–36. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Егоров В.В., Поваляева Д.А., Смолякова Г.П. и др. Новые возможности повышения эффективности патогенетического лечения оптического неврита. РМЖ «Клиническая офтальмология». 2016; (3): 140–4.</mixed-citation><mixed-citation xml:lang="en">Egorov V.V., Povalyaeva D.A., Smolyakova G.P., et al. New features to increase the efficiency of pathogenetic treatment of optic neuritis. RMJ Clinical ophthalmology. 2016; (3): 140–4. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Поваляева Д.А. Егоров В.В., Смолякова Г.П. и др. Герпес-вирусная инфекция как этиологический фактор острого идиопатического оптического неврита. Вестник офтальмологии. 2019;135(2):4-11. https://doi.org/10.17116/oftalma20191350214</mixed-citation><mixed-citation xml:lang="en">Поваляева Д.А. Егоров В.В., Смолякова Г.П. и др. Герпес-вирусная инфекция как этиологический фактор острого идиопатического оптического неврита. Вестник офтальмологии. 2019;135(2):4-11. [Povaliaeva D.A., Egorov V.V, Smolyakova G.P., et al. Herpesviral infection as an etiological factor of acute idiopathic optic neuritis. Vestnik Oftal’mologii. 2019;135(2):4-11. (In Russ.). https://doi.org/10.17116/oftalma20191350214</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ширалиева Р.К., Годжаева А.M., Несруллаева Н.А. Клиническая характеристика пациентов с рассеянным склерозом и оптическим невритом в дебюте. National journal of neurology. 2018; 1(13):34-40.</mixed-citation><mixed-citation xml:lang="en">Shiraliyeva R.K., Godjayeva A.M., Nesrullayeva N.A. Clinical characteristics of patients with multiplesclerosis and optic neuritis in the debut. National journal of neurology. 2018; 1(13):34-40 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ширалиева Р.К., Годжаева А.M., Несруллаева Н.А. Клиническая характеристика пациентов с рассеянным склерозом и оптическим невритом в дебюте. National journal of neurology. 2018; 1(13):34-40.</mixed-citation><mixed-citation xml:lang="en">Shiraliyeva R.K., Godjayeva A.M., Nesrullayeva N.A. Clinical characteristics of patients with multiplesclerosis and optic neuritis in the debut. National journal of neurology. 2018; 1(13):34-40 (In Russian)].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Железникова Г.Ф., Скрипченко Н.В., Иванова Г.П., Суровцева А.В., Скрипченко Е.Ю. Герпес-вирусы и рассеянный склероз. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(9):133 43. https://doi.org/10.17116/jnevro201611691133-143</mixed-citation><mixed-citation xml:lang="en">Zheleznikova G.F., Skripchenko N.V., Ivanova G.P., Surovtseva A.V., Scripchenko E.Y. Gerpes viruses and multiple sclerosis. Zhurnal Nevrologii I Psikhiatrii imeni S.S. Korsakova. 2016;116(9):133 43. (In Russ.) https://doi.org/10.17116/jnevro201611691133-143</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Venkatesan A, Johnson RT. Infections and multiple sclerosis. Handbook of clinical neurology. 2014; 122:151-71. https://doi.org/10.1016/B978-0-444-52001-2.00007-8</mixed-citation><mixed-citation xml:lang="en">Venkatesan A, Johnson RT. Infections and multiple sclerosis. Handbook of clinical neurology. 2014; 122:151-71. https://doi.org/10.1016/B978-0-444-52001-2.00007-8</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bartsch T. The spectrum of progressive multifocal leukoencephalopathy: A practical approach. Eur. J. Neurol. 2019; 26(4): 566-e41. https://doi.org/10.1111/ene.13906</mixed-citation><mixed-citation xml:lang="en">Bartsch T. The spectrum of progressive multifocal leukoencephalopathy: A practical approach. Eur. J. Neurol. 2019; 26(4): 566-e41. https://doi.org/10.1111/ene.13906</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. In: Seminars in neurology. 2016. 36(2):103-14. https://doi.org/10.1055/s-0036-1579693</mixed-citation><mixed-citation xml:lang="en">Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. In: Seminars in neurology. 2016. 36(2):103-14. https://doi.org/10.1055/s-0036-1579693</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Najafi S, Ghane M, Poortahmasebi V, Jazayeri SM, Yousefzadeh-Chabok S. Prevalence of herpes simplex virus infection in patients with relapsing-remitting multiple sclerosis: a case-control study in the North of Iran. Arch Clin Infect Dis. 2016;11(3):e36576. https://doi.org/10.5812/archcid.36576</mixed-citation><mixed-citation xml:lang="en">Najafi S, Ghane M, Poortahmasebi V, Jazayeri SM, Yousefzadeh-Chabok S. Prevalence of herpes simplex virus infection in patients with relapsing-remitting multiple sclerosis: a case-control study in the North of Iran. Arch Clin Infect Dis. 2016;11(3):e36576. https://doi.org/10.5812/archcid.36576</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Гончарова З.А., Беловолова Р.А., Мегерян В.А., Ярош Н.М. Влияние персистирующей герпетической инфекции на течение рассеянного склероза. Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. 2015;13(1):38-43.</mixed-citation><mixed-citation xml:lang="en">Goncharova Z.A., Belovolova R.A., Megeryan V.A., Yarosh N.M. An influence of persistent herpes viral infection on the course of multiple sclerosis. Vestnik Novosibirsk State University. Series: Biology, clinical medicine. 2015;13(1):38-43. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Сорокина К.Б., Чичановская Л.В., Бахарева О.Н., Ястребова Е.Н. Статистический анализ эпидемиологических особенностей течения рассеянного склероза в Тверской области. Вестник Тверского государственного университета. Серия: Экономика и управление. 2014; 1:340-349.</mixed-citation><mixed-citation xml:lang="en">Sorokina K. B., Chichanovskaja L. V., Bahareva O. N., Jastrebova E. N. Статистический анализ эпидемиологических особенностей течения рассеянного склероза в Тверской области. Statistical analysis of the epidemiological characteristics of the multiple sclerosis course in the Tver region. Vestnik Tverskogo gosudarstvennogo universiteta. Ser.: Jekonomika i upravlenie. 2014; 1: 340–9. (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bello-Morales R, Andreu S, López-Guerrero JA. The role of herpes simplex virus type 1 infection in demyelination of the central nervous System. International Journal of Molecular Sciences. 2020; 21(14):5026 https://doi.org/10.3390/ijms21145026</mixed-citation><mixed-citation xml:lang="en">Bello-Morales R, Andreu S, López-Guerrero JA. The role of herpes simplex virus type 1 infection in demyelination of the central nervous System. International Journal of Molecular Sciences. 2020; 21(14):5026 https://doi.org/10.3390/ijms21145026</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Duarte LF, Farías MA, Álvarez DM, et al. Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders. Frontiers in Cellular Neuroscience. 2019; 13:46 https://doi.org/10.3389/fncel.2019.00046</mixed-citation><mixed-citation xml:lang="en">Duarte LF, Farías MA, Álvarez DM, et al. Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders. Frontiers in Cellular Neuroscience. 2019; 13:46 https://doi.org/10.3389/fncel.2019.00046</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Кричевская Г.И. Роль вируса герпеса человека 6 типа (ВГЧ-6) в общей патологии и при заболеваниях глаз. Российский офтальмологический журнал. 2016;9(1):98-104. https://doi.org/10.21516/2072-0076-2016-9-1-98-104</mixed-citation><mixed-citation xml:lang="en">Krichevskaya G.I. The role of human herpesvirus-6 (HHV-6) in general pathology and ocular inflammatory disorders. Russian Ophthalmological Journal. 2016; 1: 98–104. (In Russ.). https://doi.org/10.21516/2072-0076-2016-9-1-98-104</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leibovitch EC, Jacobson S. Evidence linking HHV-6 with multiple sclerosis: an update. Current opinion in virology. 2014; 9:127-33 https://doi.org/10.1016/j.coviro.2014.09.016</mixed-citation><mixed-citation xml:lang="en">Leibovitch EC, Jacobson S. Evidence linking HHV-6 with multiple sclerosis: an update. Current opinion in virology. 2014; 9:127-33 https://doi.org/10.1016/j.coviro.2014.09.016</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Soldan SS, Fogdell-Hahn, Brennan M.B. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2001; 50(4): 486–93 https://doi.org/10.1002/ana.1135</mixed-citation><mixed-citation xml:lang="en">Soldan SS, Fogdell-Hahn, Brennan M.B. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2001; 50(4): 486–93 https://doi.org/10.1002/ana.1135</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson JrS, Taylor B, Dwyer DE, et al. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Multiple Sclerosis Journal. 2012; 18(6):799-806 https://doi.org/10.1177/1352458511428081</mixed-citation><mixed-citation xml:lang="en">Simpson JrS, Taylor B, Dwyer DE, et al. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Multiple Sclerosis Journal. 2012; 18(6):799-806 https://doi.org/10.1177/1352458511428081</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis. Journal of cellular physiology. 2018; 233(4):2850–62 https://doi.org/10.1002/jcp.26000</mixed-citation><mixed-citation xml:lang="en">Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis. Journal of cellular physiology. 2018; 233(4):2850–62 https://doi.org/10.1002/jcp.26000</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS ONE. 2018, 13(2): e0192109 https://doi.org/10.1371/journal.pone.0192109</mixed-citation><mixed-citation xml:lang="en">Hassani A, Corboy JR, Al-Salam S, Khan G. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS ONE. 2018, 13(2): e0192109 https://doi.org/10.1371/journal.pone.0192109</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Waubant E, Mowry EM, Krupp L, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011; 76(23):1989-95 https://doi.org/10.1212/WNL.0b013e31821e552a</mixed-citation><mixed-citation xml:lang="en">Waubant E, Mowry EM, Krupp L, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011; 76(23):1989-95 https://doi.org/10.1212/WNL.0b013e31821e552a</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Скрипченко Е.Ю., Железникова Г.Ф., Алексеева Л.А. и др. Герпесвирусы и биомаркеры при диссеминированном энцефаломиелите и рассеянном склерозе у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121(3):138-45. https://doi.org/10.17116/jnevro2021121031138</mixed-citation><mixed-citation xml:lang="en">Skripchenko E.Yu., Zheleznikova G.F., Alekseeva L.A., et al. Herpesviruses and biomarkers in disseminated encephalomyelitis and multiple sclerosis in children. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(3):138–45. (In Russ.). https://doi.org/10.17116/jnevro2021121031138</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: A comprehensive review. Neurology and therapy. 2018; 7(1):59-85 https://doi.org/10.1007/s40120-017-0086-4</mixed-citation><mixed-citation xml:lang="en">Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: A comprehensive review. Neurology and therapy. 2018; 7(1):59-85 https://doi.org/10.1007/s40120-017-0086-4</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Morandi E, Tanasescu R, Tarlinton RE, Constantin-Teodosiu D, Gran B. Do antiretroviral drugs protect from multiple sclerosis by inhibiting expression of ms-associated retrovirus? Front. Immunol. 2019; 9:3092 https://doi.org/10.3389/fimmu.2018.03092</mixed-citation><mixed-citation xml:lang="en">Morandi E, Tanasescu R, Tarlinton RE, Constantin-Teodosiu D, Gran B. Do antiretroviral drugs protect from multiple sclerosis by inhibiting expression of ms-associated retrovirus? Front. Immunol. 2019; 9:3092 https://doi.org/10.3389/fimmu.2018.03092</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова М.Н., Логунов Д.Ю., Кочергин И.А., Бакулин И.С. Эндогенные ретровирусы: от фундаментальных исследований к этиотропной терапии рассеянного склероза. Анналы клинической и экспериментальной неврологии. 2015; 9(4):49-53.</mixed-citation><mixed-citation xml:lang="en">Zakharova M.N., Logunov D.Y., Kochergin I.A., Bakulin I.S. Endogenous retrovirus: from fundamental studies to etiotropic therapy of multiple sclerosis. Annals of Clinical and Experimental Neurology. 2015; 9(4):49-53 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Pakpoor J, Disanto G, Gerber JE, et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Multiple Sclerosis Journal. 2013;19(2):162-6. doi:10.1177/1352458512449682</mixed-citation><mixed-citation xml:lang="en">Pakpoor J, Disanto G, Gerber JE, et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Multiple Sclerosis Journal. 2013;19(2):162-6. doi:10.1177/1352458512449682</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Кричевская Г.И., Слепова О.С., Танковский В.Э., Уракова Н.А. Инфекционный статус больных с воспалительными окклюзиями вен сетчатки. Российский офтальмологический журнал. 2013; 6(4): 38-41.</mixed-citation><mixed-citation xml:lang="en">Neroev VV, Krichevskaya GI, Slepova OS, Tankovsky VE, Urakova NA. The infectious status of patients with inflammatory retinal vein occlusions. Russian Ophthalmological Journal. 2013;6(4):38-41. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецова Т.И., Астахов Ю.С. Можно ли сократить долю увеитов неясной этиологии? Офтальмологические ведомости. 2019; 12(3):21-30. doi: 10.17816/OV16369</mixed-citation><mixed-citation xml:lang="en">Kuznetcova T.I., Astakhov Y.S. Is it possible to cut down the number of unknown etiology in uveitis? Ophthalmology Reports. 2019; 12(3): 21-30. (In Russ.) doi: 10.17816/OV16369</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Чернакова Г.М., Майчук Д.Ю., Малышева З.Г. и др. Результаты иммуноферментного анализа сыворотки крови при инфекционно-воспалительных заболеваниях переднего сегмента глаза. Вестник офтальмологии. 2020;136(2):32-7. https://doi.org/10.17116/oftalma202013602132</mixed-citation><mixed-citation xml:lang="en">Chernakova G.M., Maychuk D.Y., Malysheva Z.G., et al. Results of enzyme-linked immunoassay of the blood serum in patients with infectious and inflammatory diseases of the anterior segment of the eye. Vestnik oftal'mologii. 2020;136(2):32-7. (In Russ.). https://doi.org/10.17116/oftalma202013602132</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Saberi R, Mehdi S, Shahabeddin S, et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. Journal of Neuroimmunology. 2018; 322:57-62 https://doi.org/10.1016/j.jneuroim.2018.06.011</mixed-citation><mixed-citation xml:lang="en">Saberi R, Mehdi S, Shahabeddin S, et al. Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. Journal of Neuroimmunology. 2018; 322:57-62 https://doi.org/10.1016/j.jneuroim.2018.06.011</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Choobdarian H, Erfan M, Zamini G, et al. Comparison of serum level of toxoplasma gondii antibody between patients with multiple sclerosis and healthy people. Int J BioMed Public Health. 2019; 2(4):66-68 doi: 10.22631/ijbmph.2018.145531.1074</mixed-citation><mixed-citation xml:lang="en">Choobdarian H, Erfan M, Zamini G, et al. Comparison of serum level of toxoplasma gondii antibody between patients with multiple sclerosis and healthy people. Int J BioMed Public Health. 2019; 2(4):66-68 doi: 10.22631/ijbmph.2018.145531.1074</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Triningrat AMP, Dewi RS, Juliari I, et al. Management of systemic steroid in HIV patient with toxoplasma papillitis. Open Access Maced J Med Sci. 2019 Jun 14;7(11):1821-4. doi: 10.3889/oamjms.2019.488</mixed-citation><mixed-citation xml:lang="en">Triningrat AMP, Dewi RS, Juliari I, et al. Management of systemic steroid in HIV patient with toxoplasma papillitis. Open Access Maced J Med Sci. 2019 Jun 14;7(11):1821-4. doi: 10.3889/oamjms.2019.488</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal A, Aggarwal K, Bansal R, et al. Toxoplasma retinochoroiditis. The Uveitis Atlas. 2020:321-327. https://doi.org/10.1007/978-81-322-2410-544</mixed-citation><mixed-citation xml:lang="en">Agarwal A, Aggarwal K, Bansal R, et al. Toxoplasma retinochoroiditis. The Uveitis Atlas. 2020:321-327. https://doi.org/10.1007/978-81-322-2410-544</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Rahimi-Esboei B, Zarei M, Mohebali M, et al. Serologic tests of IgG and IgM antibodies and IgG avidity for diagnosis of ocular toxoplasmosis. The Korean journal of parasitology. 2018; 56(2):147-52. https://doi.org/10.3347/kjp.2018.56.2.147</mixed-citation><mixed-citation xml:lang="en">Rahimi-Esboei B, Zarei M, Mohebali M, et al. Serologic tests of IgG and IgM antibodies and IgG avidity for diagnosis of ocular toxoplasmosis. The Korean journal of parasitology. 2018; 56(2):147-52 https://doi.org/10.3347/kjp.2018.56.2.147</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
